These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 8759097)
1. Bradykinin and its metabolite, Arg-Pro-Pro-Gly-Phe, are selective inhibitors of alpha-thrombin-induced platelet activation. Hasan AA; Amenta S; Schmaier AH Circulation; 1996 Aug; 94(3):517-28. PubMed ID: 8759097 [TBL] [Abstract][Full Text] [Related]
2. Mechanisms of Arg-Pro-Pro-Gly-Phe inhibition of thrombin. Hasan AA; Warnock M; Nieman M; Srikanth S; Mahdi F; Krishnan R; Tulinsky A; Schmaier AH Am J Physiol Heart Circ Physiol; 2003 Jul; 285(1):H183-93. PubMed ID: 12598231 [TBL] [Abstract][Full Text] [Related]
3. Synthesis of novel peptide inhibitors of thrombin-induced platelet activation. Burke FM; Warnock M; Schmaier AH; Mosberg HI Chem Biol Drug Des; 2006 Nov; 68(5):235-8. PubMed ID: 17177882 [TBL] [Abstract][Full Text] [Related]
4. Developing peptide inhibitors to thrombin activation of platelets from bradykinin analogs. Hasan AA; Warnock M; Srikanth S; Schmaier AH Thromb Res; 2001 Dec; 104(6):451-65. PubMed ID: 11755956 [TBL] [Abstract][Full Text] [Related]
5. The preparation and characterization of novel peptide antagonists to thrombin and factor VIIa and activation of protease-activated receptor 1. Nieman MT; Warnock M; Hasan AA; Mahdi F; Lucchesi BR; Brown NJ; Murphey LJ; Schmaier AH J Pharmacol Exp Ther; 2004 Nov; 311(2):492-501. PubMed ID: 15210836 [TBL] [Abstract][Full Text] [Related]
6. Mapping the interaction of bradykinin 1-5 with the exodomain of human protease activated receptor 4. Nieman MT; Pagan-Ramos E; Warnock M; Krijanovski Y; Hasan AA; Schmaier AH FEBS Lett; 2005 Jan; 579(1):25-9. PubMed ID: 15620686 [TBL] [Abstract][Full Text] [Related]
7. Bradykinin and its metabolite bradykinin 1-5 inhibit thrombin-induced platelet aggregation in humans. Murphey LJ; Malave HA; Petro J; Biaggioni I; Byrne DW; Vaughan DE; Luther JM; Pretorius M; Brown NJ J Pharmacol Exp Ther; 2006 Sep; 318(3):1287-92. PubMed ID: 16772538 [TBL] [Abstract][Full Text] [Related]
8. The serine protease granzyme A does not induce platelet aggregation but inhibits responses triggered by thrombin. Suidan HS; Clemetson KJ; Brown-Luedi M; Niclou SP; Clemetson JM; Tschopp J; Monard D Biochem J; 1996 May; 315 ( Pt 3)(Pt 3):939-45. PubMed ID: 8645180 [TBL] [Abstract][Full Text] [Related]
10. Thrombin-induced platelet aggregation is inhibited by the heptapeptide Leu271-Ala277 of domain 3 in the heavy chain of high molecular weight kininogen. Kunapuli SP; Bradford HN; Jameson BA; DeLa Cadena RA; Rick L; Wassell RP; Colman RW J Biol Chem; 1996 May; 271(19):11228-35. PubMed ID: 8626672 [TBL] [Abstract][Full Text] [Related]
11. Characterization of in vitro and in vivo platelet responses to thrombin and thrombin receptor-activating peptides in guinea pigs. Chiu PJ; Tetzloff GG; Foster C; Chintala M; Sybertz EJ Eur J Pharmacol; 1997 Feb; 321(1):129-35. PubMed ID: 9083795 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of thrombin and SFLLR-peptide stimulation of platelet aggregation, phospholipase A2 and Na+/H+ exchange by a thrombin receptor antagonist. Seiler SM; Peluso M; Michel IM; Goldenberg H; Fenton JW; Riexinger D; Natarajan S Biochem Pharmacol; 1995 Feb; 49(4):519-28. PubMed ID: 7872957 [TBL] [Abstract][Full Text] [Related]
13. Thrombin receptor-mediated vascular relaxation differentiated by a receptor antagonist and desensitization. Tesfamariam B Am J Physiol; 1994 Nov; 267(5 Pt 2):H1962-7. PubMed ID: 7526715 [TBL] [Abstract][Full Text] [Related]